Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

AR 101

Next Previous
Search
Drug Profile

AR 101

Alternative Names: AR-101-Aimmune-Therapeutics; AR101; Arachis hypogaea Allergen Powder-dnfp; Characterised-peanut-allergen-oral-immunotherapy-ARC; CPNA-Aimmune-Therapeutics; defatted powder of Arachis hypogaea L; PALFORZIA; Peanut (Arachis hypogaea) allergaen powder-dnfp; Peanut Allergen Powder-dnfp; Peanut allergy immunotherapy - Aimmune Therapeutics; Peanut allergy OIT - Aimmune Therapeutics; semen; semen (peanuts)

Latest Information Update: 12 Mar 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Allergen Research Corporation
  • Developer Aimmune Therapeutics; Regeneron Pharmaceuticals; Sanofi; Stallergenes Greer plc
  • Class Allergens; Antiallergics; Food allergy immunotherapies
  • Mechanism of Action Immunomodulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Peanut hypersensitivity

Most Recent Events

  • 28 Feb 2025 Launched for Peanut hypersensitivity (In infants) in USA (PO)
  • 09 Jan 2025 Registered for Peanut hypersensitivity (In children, In infants) in Iceland, Norway, Liechtenstein and European Union (PO)
  • 02 Dec 2024 Preregistered for Peanut hypersensitivity (In children, In infants) in Iceland, Norway, Liechtenstein and European Union (PO)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top